Product List

Product List

 

Declaration: ScinoPharm Taiwan, Ltd. will not offer for commercial sale the below listed APIs to regions or countries where substance patents remain valid.

 

API Under Development Samples Available Soon

 

  • Abemaciclib
  • Tucatinib
  • Alectinib HCl
  • Zanubrutinib
  • Alpelisib
   

     

 

 

 

 

 

 

Patent restraints in certain countries restrict the availability of selected products listed below.

Currently Available APIs with US DMF and/or EDMF Registrations

 

  • Anastrozole
  • Gefitinib
  • Apixaban 
  • Gemcitabine HCI
  • Apremilast
  • Granisetron HCI
  • Azacitidine 
  • Ibrutinib
  • Benazepril HCI
  • Irinotecan HCI
  • Bimatoprost 
  • Ivacaftor
  • Bivalirudin
  • Lapatinib ditosylate
  • Bortezomib 
  • Letrozole
  • Brexpiprazole 
  • Lifitegrast
  • Capecitabine 
  • Nelarabine
  • Cedazuridine 
  • Octreotide acetate
  • Cladribine
  • Olaparib
  • Dantrolene Na
  • Osimertinib mesylate
  • Decitabine 
  • Paclitaxel
  • Docetaxel anhydrous
  • Palbociclib
  • Docetaxel trihydrate
  • Regadenoson*
  • Elagolix Na
  • Riluzole
  • Entecavir
  • Roflumilast
  • Enzalutamide
  • SN38
  • Exemestane
  • Tamsulosin HCI
  • Flumazenil
  • Topiramate
  • Fulvestrant
  • Topotecan HCI
  • Galantamine
  • Travoprost
  • Galantamine HBr
  • Zoledronic acid

*API with exclusivity committed in certain areas